Rx (Prescription Medicine)
USD $ 30.00
Cabotib 40mg Tablet 是一种含有 Cabozantinib 为活性成分的药物。Cabozantinib 是一种酪氨酸激酶抑制剂，通过阻断某些促进癌细胞生长和存活的蛋白质的活性起作用。它可靶向多种受体酪氨酸激酶，包括 VEGFR、MET、RET、KIT、FLT3，这些受体参与肿瘤生长、血管生成（肿瘤供血新血管的形成）以及转移（癌症向身体其他部位的扩散）。
Cabotib 40mg Tablet 主要用于治疗转移性肾细胞癌（肾癌）和已接受过系统治疗的肝细胞癌（一种肝癌类型）患者。它也可能用于其他类型的癌症，具体取决于诊断结果和治疗指南。
Cabotib 40mg Tablet 的典型剂量由医疗专业人员根据患者的病情和治疗反应确定。通常口服服用，可与食物同服或空腹服用。务必遵循医师 prescribed 的剂量和治疗周期。常见的不良反应可能包括腹泻、疲劳、恶心、呕吐、食欲下降、高血压、皮疹以及手足综合征。严重的不良反应也可能发生，如出现任何异常症状，请立即向医生报告。Cabotib 40mg Tablet 应储存在室温，避免潮湿和热源。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Cabozantinib 40 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
